VVT Med Inc.

As of June 30, 2026, VVT Med Inc. has 68.62M shares outstanding.

As of June 30, 2026, VVT Med Inc. maintains a current ratio of 0.16, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -63.70, indicating conservative leverage, while an interest coverage ratio of -25.57 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -382.85, reflecting losses generated across the asset base. Inventory turnover of 0.13 indicates how many times VVT Med Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on August 28, 2026, VVT Med Inc.'s stock has declined approximately 89.89% over the past 52 weeks. The 50-day moving average sits at 6.72, while the 200-day moving average is 12.19.

Over the twelve months ended June 30, 2026, VVT Med Inc. generated 136,244.16 in revenue and converted that into -5.83M in net income, yielding earnings per share of -0.09. EBITDA reached -7.40M, while operating income came in at -7.62M.

As of June 30, 2026, VVT Med Inc. holds 12,772.89 in cash and equivalents against 1.65M in total debt, resulting in a net debt position of 949,451.49. Total book value stands at -2.60M, with working capital of -2.86M providing operational flexibility.

VVT Med Inc. produced -4.66M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -7,096.05 in capital expenditures, free cash flow totaled -4.67M - equivalent to -0.07 per share.

Over the twelve months ended June 30, 2026, VVT Med Inc. posted a gross margin of 63.54, reflecting its pricing power and cost economics. The operating margin of -5,592.71 and net profit margin of -4,279.17 provide insight into operational efficiency.

VVT Med Inc.'s most recent stock split took place on July 31, 2025.